CD24 and cholangiocarcinoma: In CCA, the expression of CD24 is associated with poor prognosis, reduced disease-free survival [110] and increased invasiveness, due to the activation of the ERK pathway and the upregulation of CXCR4, the cognate receptor for SDF-1/CXCL12 [111].